Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02284113 · ClinicalTrials.gov registry record · NA
A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty
A NA study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT02284113 is a NA study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 150 participants.
The verdict
NCT02284113, a NA study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will evaluate the iovera° device in treating pain associated with total knee arthroplasty (TKA). This study will also assess if overall pain medication is reduced following TKA and will investigate the relationship between patients treated with the iovera° device and length of hospital stay, pain, patient satisfaction and improved rehabilitation.
Interventions
- DEVICE iovera°
- DEVICE iovera° Sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02284113
The ClinicalTrials.gov registry entry for NCT02284113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iovera° is the first listed.
NCT02284113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02284113 about?
NCT02284113 is a clinical study titled "A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty". This study will evaluate the iovera° device in treating pain associated with total knee arthroplasty (TKA). This study will also assess if overall pain medication is reduced following TKA and will investigate the relationship between patients treated with the iovera° device and length of hospital st...
What is the current status of trial NCT02284113?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2014-12. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02284113?
The interventions under investigation include: iovera° (DEVICE), iovera° Sham (DEVICE).
Who is sponsoring clinical trial NCT02284113?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.